Literature DB >> 25551129

Henoch-Schönlein purpura in children: limited benefit of corticosteroids.

Joel Bluman, Ran D Goldman.   

Abstract

QUESTION: A child recently presented to my office with lower limb petechiae, arthralgia, and abdominal pain characteristic of Henoch-Schönlein purpura (HSP). Will systemic corticosteroids help relieve these symptoms and prevent potential HSP complications such as intussusception and nephritis? ANSWER: Henoch-Schönlein purpura is a common and self-limiting disease in children. Current evidence does not support universal treatment of HSP with corticosteroids. Recent trials and meta-analyses found that corticosteroids do not prevent the onset of renal disease or abdominal complications. However, corticosteroids are effective as treatment of abdominal pain, arthralgia, and purpura. Clinicians are advised to use their discretion in choosing which patients might benefit most from oral corticosteroid treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25551129      PMCID: PMC4229160     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  18 in total

1.  Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins.

Authors:  Janet M M Gardner-Medwin; Pavla Dolezalova; Carole Cummins; Taunton R Southwood
Journal:  Lancet       Date:  2002-10-19       Impact factor: 79.321

2.  Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura.

Authors:  F Mollica; S Li Volti; R Garozzo; G Russo
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

Review 3.  Schönlein-henoch purpura in children and adults: diagnosis, pathophysiology and management.

Authors:  G Rostoker
Journal:  BioDrugs       Date:  2001       Impact factor: 5.807

Review 4.  Diagnosis and management of cutaneous vasculitis in children.

Authors:  Tracy V Ting
Journal:  Pediatr Clin North Am       Date:  2014-01-21       Impact factor: 3.278

5.  Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebo-controlled trial.

Authors:  Jaana Ronkainen; Olli Koskimies; Marja Ala-Houhala; Marjatta Antikainen; Jussi Merenmies; Jukka Rajantie; Timo Ormälä; Juha Turtinen; Matti Nuutinen
Journal:  J Pediatr       Date:  2006-08       Impact factor: 4.406

Review 6.  Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review.

Authors:  H Narchi
Journal:  Arch Dis Child       Date:  2005-05-04       Impact factor: 3.791

Review 7.  Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review.

Authors:  Pamela F Weiss; James A Feinstein; Xianqun Luan; Jon M Burnham; Chris Feudtner
Journal:  Pediatrics       Date:  2007-11       Impact factor: 7.124

Review 8.  Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP).

Authors:  Wattana Chartapisak; Sauwalak Opastirakul; Elisabeth M Hodson; Narelle S Willis; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

9.  Henoch Schonlein purpura in childhood: clinical analysis of 254 cases over a 3-year period.

Authors:  Harun Peru; Oguz Soylemezoglu; Sevcan Azime Bakkaloglu; Sefika Elmas; Davut Bozkaya; Ahmet Midhat Elmaci; Fatih Kara; Necla Buyan; Enver Hasanoglu
Journal:  Clin Rheumatol       Date:  2008-02-28       Impact factor: 2.980

10.  A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein Purpura [ISRCTN85109383].

Authors:  Adam M Huber; Jim King; Peter McLaine; Terry Klassen; Mary Pothos
Journal:  BMC Med       Date:  2004-04-02       Impact factor: 8.775

View more
  8 in total

1.  Atypical purpura location in a Sudanese infant with Henoch-Schönlein purpura.

Authors:  Mumen Abdalazim Dafallah; Alaa Abdualazem Dafalla; Esraa Ahmed Ragab; Fawzeia Hamad
Journal:  Sudan J Paediatr       Date:  2021

Review 2.  Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature.

Authors:  Roberta Fenoglio; Carla Naretto; Bruno Basolo; Giacomo Quattrocchio; Michela Ferro; Paola Mesiano; Giulietta Beltrame; Dario Roccatello
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

3.  Treatment of Henoch Schonlein nephritis; new trends.

Authors:  Azar Nickavar
Journal:  J Nephropathol       Date:  2016-07-28

4.  Henoch-Schonlein purpura due to sodium valproate: A case report.

Authors:  Firozeh Hosseini; Mojgan Safari
Journal:  Clin Case Rep       Date:  2022-03-22

5.  A Case Report on an Adult Presentation of Henoch-Schönlein Purpura.

Authors:  Raja Sood; Priya Parekh; Nitish Raj; Iqra Saani
Journal:  Cureus       Date:  2022-06-28

6.  Henoch-Schönlein purpura with joint involvement: Analysis of 71 cases.

Authors:  Xuehong Wang; Yongmei Zhu; Laiqiang Gao; Shuyue Wei; Youyou Zhen; Qiang Ma
Journal:  Pediatr Rheumatol Online J       Date:  2016-03-31       Impact factor: 3.054

7.  Clinical features and outcomes of diffuse endocapillary proliferation Henoch-Schönlein purpura nephritis in children.

Authors:  Haidong Fu; Jianhua Mao; Yanping Xu; Weizhong Gu; Xiujuan Zhu; Aimin Liu
Journal:  Clinics (Sao Paulo)       Date:  2016-09       Impact factor: 2.365

8.  Clinico-Epidemiological Profile and Outcome of Children with IgA Vasculitis in Aseer Region, Southwestern Saudi Arabia.

Authors:  Samy A Dawood; Abdoh M Abodiah; Saleh M Alqahtani; Ayed A Shati; Youssef A Alqahtani; Mohammed A Alshehri; Syed E Mahmood
Journal:  Healthcare (Basel)       Date:  2021-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.